SCHEMBL671223

SCHEMBL671223

CCNC(=O)C1CC=CCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
ALOX15 P16050 1/20 0.49
HTT P42858 1/20 0.49
KMT2A Q03164 1/20 0.49
ESR2 Q92731 1/20 0.49
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
RAB9A P51151 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
BCHE P06276 1/20 0.37
EPHX1 P07099 1/20 0.37
KDM4E B2RXH2 2/20 0.37
PKM P14618 1/20 0.36
KDM5A P29375 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2404722 0.86 HSD17B10 (0.46) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL23374501 0.86 HSD17B10 (0.46) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL15717383 0.85 EPHX1 (0.39) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL2534227 0.85 EPHX1 (0.39) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL19974223 0.83 KMT2A (0.50) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL2407153 0.80 NAAA (0.60) EPHX1POLBGNAI3GNAO1GNAI1
SCHEMBL9925959 0.79 KMT2A (0.46) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL2128104 0.79 ALDH1A1 (0.53) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL20034368 0.78 ALDH1A1 (0.35) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL13830559 0.76 RAB9A (0.50) KMT2ARAB9ABCHEEPHX1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130059850-A1 AZA-INDOLE DERIVATIVES USEFUL AS MODULATORS OF FAAH MERCK SHARP & DOHME CORP. (US) 2013-03-07 US claimed
JP-1279860-A None JP disclosed
EP-2606033-A1 SUBSTITUTED CYCLIC CARBOXAMIDE AND UREA DERIVATIVES AS LIGANDS OF THE VANILLOID RECEPTOR Grünenthal GmbH (DE) 2013-06-26 EP disclosed
WO-2012022487-A1 SUBSTITUTED CYCLIC CARBOXAMIDE AND UREA DERIVATIVES AS LIGANDS OF THE VANILLOID RECEPTOR Grünenthal GmbH (DE) 2012-02-23 WO disclosed
JP-H01279860-A AMIDE COMPOUND SUMITOMO CHEM CO LTD 1989-11-10 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059850-A1 AZA-INDOLE DERIVATIVES USEFUL AS MODULATORS OF FAAH FAAH, FAAH2, IDO1 ALDH1A1 1530/4885HSD17B10 2514/4885MEN1 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.